Thoratec (THOR) Tops Q1 EPS by 12c

Thoratec (NASDAQ: THOR) reported Q1 EPS of $0.38, $0.12 better than the analyst estimate of $0.26. Revenue for the quarter came in at $121.3 million versus the consensus estimate of $111.1 million.

For earnings history and earnings-related data on Thoratec (THOR) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
• Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance